Comparing Patient Satisfaction With Pataday or Bepreve (NCT01450176) | Clinical Trial Compass
CompletedNot Applicable
Comparing Patient Satisfaction With Pataday or Bepreve
United States30 participantsStarted 2011-09
Plain-language summary
The purpose of this study is to compare patient satisfaction with Pataday (Olopatadine hydrochloride 0.2%) one daily (QD) and Bepreve (Bepotastine besilate ophthalmic solution 1.5%) two times a day (BID).
Who can participate
Age range18 Years
SexALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Be male or female subjects of any racial/ethnic group.
* Be at least 18 years of age or older.
* Have a diagnosis of allergic conjunctivitis with active symptoms, with no concurrent ocular allergy associated conditions and no plans to have ocular surgery during study period.
* Willing and able to return for all required visits and follow instructions from investigator and staff.
* Able to self-administer test article (TA) or have a caregiver available to instill all doses of TA.
* If a woman, capable of becoming pregnant, agrees to have pregnancy testing performed at screening (must be negative) and agrees to use a medically acceptable form of birth control (intrauterine device, birth control pill, patch or subcutaneous implant, condoms, diaphragm, and abstinence) throughout the study duration and for at least one week prior to and one week after completion of the study. Women considered capable of becoming pregnant include all females who have experienced menarche and who have not experienced menopause (as defined by amenorrhea for greater than 12 consecutive months) or have not undergone successful surgical sterilization (hysterectomy, bilateral tubal ligation, or bilateral oophorectomy).
* Sign and date the informed consent form approved by an Institutional Review Board (IRB)/Independent Ethics Committee (IEC).
* Be willing/able to return for all required study visits, to follow instructions from the study investigator and his/her staff, and to complā¦